Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Blair James C
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   127,185    

Indirect Shares

  2,985,991      
Direct Value   $138,020    

Indirect Value

  $10,134,763      
Total Shares   3,113,176      
Total Value   $10,272,783      


Nuvasive Inc
 $137,416 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $103 Clovis Oncology, Inc.
 $502 Nuvasive Inc
 $137,416 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $103 Clovis Oncology, Inc.
 $502
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Welltek Incorporated WTKND Director 2008-03-07 0 2008-03-07 0    Premium*  
            Nuvasive Inc NUVA Director 2007-05-09 3,457 2007-05-09 0    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 70,916 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 19,373 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX Director, 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS Director 2019-08-16 33,439 2019-08-20 30,105    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
* Premium Members only  

Records found :    183         Free Registration Required For Full Results.    Limit: 25

Download
  Page 7 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-12-17 4 B $7.55 $755,000 I/I 100,000 42,122 1.5 -
NUVA Nuvasive Inc Director   –       •      –    2005-11-02 4 S $16.66 $786,494 I/I (47,200) 12,886 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-11 4 B $7.60 $792,680 I/I 104,300 20,887 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-23 4 B $6.93 $1,039,500 I/I 150,000 39,606 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-08 4 B $4.47 $1,110,397 I/I 248,411 4,173 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-09 4 B $4.93 $1,192,518 I/I 241,890 8,237 1.5 -
NUVA Nuvasive Inc Director   –       •      –    2005-11-14 4 S $17.02 $1,407,826 I/I (82,716) 8,919 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2017-08-04 4 S $78.61 $1,450,355 I/I (18,450) 17,056 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-20 4 B $6.93 $1,732,500 I/I 250,000 37,090 1.5 -
WTKND Welltek Incorporated Director   –       •      –    2006-05-02 4 B $19.01 $1,958,030 I/I 103,000 2,277 2.1 -
WTKND Welltek Incorporated Director   –       •      –    2006-05-01 4 S $19.03 $2,127,554 I/I (111,800) 1,185 -
WTKND Welltek Incorporated Director   –       •      –    2006-06-13 4 B $17.14 $2,457,876 I/I 143,400 15,900 2.1 -
PRTK Paratek Pharmaceuticals I... Director   –       •       •   2006-05-15 4 B $6.50 $2,999,997 I/I 461,538 98,075 2.25 -
TBRA Tobira Therapeutics Inc 10% Owner   –       –       •   2013-08-27 4 B $4.00 $3,000,000 I/I 750,000 2,571,117 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-12 4 B $8.00 $3,200,000 I/I 400,000 27,595 1.5 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 B $14.00 $3,999,996 I/I 285,714 35,253 1.5 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2010-04-27 4 B $11.00 $4,158,308 I/I 378,028 4,829,773 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-07-23 4 B $7.50 $4,875,000 I/I 650,000 19,138 1.5 -
WTKND Welltek Incorporated Director   –       •      –    2006-06-12 4 B $17.34 $5,635,500 I/I 325,000 14,380 2.1 -
WTKND Welltek Incorporated Director   –       •      –    2006-05-04 4 B $19.98 $5,698,296 I/I 285,200 10,600 2.1 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 B $12.00 $6,300,000 I/I 525,000 104,975 1.5 -
ZGNX Zogenix, Inc. Director   –       •       •   2011-09-16 4 B $2.00 $7,000,000 I/I 3,500,000 169,251 2.25 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 B $9.00 $7,058,817 I/I 784,313 22,306 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2013-07-15 4 B $6.03 $7,999,992 I/I 1,327,491 1,897,336 1.5 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2013-07-15 4/A B $6.03 $7,999,992 I/I 1,327,491 1,857,036 1.5 -

  183  Records found
  1   2   3   4   5   6   7  8      
  Page 7 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed